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confidence interval was used to examine the association
between BMI & pathological characteristics of PTC.

Abstract
Background: Incidence of papillary thyroid carcinoma
(PTC) and the frequency of obesity is increasing globally.
In literature, relationship between excessive body weight
and bad prognostic features of PTC is still debatable. In
this study, we aimed to explore the association of obesity
with high risk pathological features of PTC in a population
treated by total thyroidectomy +/- neck dissection.

Results: A total of 53 patients were treated for PTC in
two-years period. There were 38 female and 15 male
patients. Twenty-eight patients had BMI in normal
while twenty-five in obese category. Patients who were
in obese category had a significantly greater risk of
having a multifocal tumor (OR=5.55, p-value=0.02) and
bilaterality (OR=6.54, p-value=0.01) compared to normal
weight patients. No positive associations were identified
between BMI and extrathyroidal extension, high T-stage,
vascular invasion and N-stage.

Materials and methods: Retrospective analysis
of patients at Aga Khan University Hospital from
January 2013 to December 2014, who underwent total
thyroidectomy +/- neck dissection due to PTC. Patients
were grouped according to World Health Organization
(WHO) classification of BMI. They were categorized
into two groups, i.e. normal (BMI= 18.5 - 24.9 kg/m2)
and obese (BMI ≥ 30 kg/m2) as none of our patients lie
in underweight and overweight category. Pathological
features i.e. T-stage, multifocality, bilaterality,
extrathyroidal extension, vascular invasion and N-stage
were assessed. All tumors were staged according to
TNM staging system proposed by 2010 American Joint
Committee on Cancer (AJCC). Odds ratio (OR) with 95%

Conclusion: Obesity is not associated with high risk
pathological features such as extrathyroidal extention,
high T-stage, vascular invasion and N-stage in PTC.
Although it has been correlated with multifocal and
bilateral tumors in this retrospective study, the presence
of these factors alone is not adequate to support the
association conclusively.

Keywords: Papillary thyroid carcinoma, Body Mass
Index, Pathological features, Total thyroidectomy, Obesity

Introduction

In literature, relationship between obesity and
pathological features of PTC is indistinct. Less aggressive
tumor features, such as the absence of nodal metastasis
and tumor invasion was reported by Paes et al 8, while
Kim et al 9 reported a positive association between obesity
and advanced tumor stage.

The frequency of obesity has increased worldwide,1 and
studies have shown that excess body weight, manifested
as a higher Body Mass Index (BMI), is associated with
increased risk of thyroid cancer and other cancers in both
genders.2-5
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Papillary thyroid carcinoma (PTC), the most common
histologic type of thyroid malignancy, is also increasing
globally.6 Although the reason for this rise in incidence are
not clear, enhanced detection of early-stage tumors with
the use of neck ultrasound and ultrasound-guided biopsy
play a major role.7
6
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In this study, we aimed to explore the association of
obesity with high risk pathological features of PTC in
a population treated by total thyroidectomy +/- neck
dissection.

to National Comprehensive Cancer Network (NCCN)
guidelines version 2.2013.12

Materials and Methods

Patient data was compiled and analyzed using
Statistical Package for Social Sciences (SPSS) Version
21. Frequency and percentage were computed for
categorical variables like gender, T-stage, multifocality,
bilaterality, extrathyroidal extension, vascular invasion
and N-stage. Mean ± SD was calculated for quantitative
variables i.e. age, weight, height and Body Mass Index
(BMI). Stratification was done on gender, age, T-stage,
multifocality, bilaterality, extrathyroidal extension, vascular
invasion and N-stage to see the effect of these modifiers
on obesity using Chi-square test and Fisher’s exact test
and p-value ≤0.05 was considered as significant.

We retrospectively reviewed medical records and
pathology reports of 101 consecutive patients with thyroid
carcinoma at Aga Khan University Hospital from January
2013 to December 2014. We excluded 48 patients with
different histologic type than PTC. Thyroid function tests
(serum TSH, free T3, and free T4) of all patients were
preoperatively checked. We also collected medical history
of diabetes mellitus, hypercholesterolemia, smoking and
alcohol intake. A total of 53 cases were included in this
study. Height and weight of each patient were recorded
from preoperative anesthesia chart and by applying the
formula of Body Mass Index (i.e., BMI = weight (kg) /
height (m2)), BMI of each patient was calculated. We
divided our cases according to World Health Organization
(WHO) classification of BMI, i.e. underweight (<18.5 kg/
m2), normal (18.5 – 24.9 kg/m2), overweight (25-29.9
kg/m2) and obese (≥30 kg/m2). None of our cases lie in
underweight and overweight category so there were two
groups in our study, i.e. normal and obese.
A standard operative procedure of total thyroidectomy
+/- neck dissection was performed in all patients in our
setting with pre-operative diagnosis of PTC by fineneedle aspiration cytology(FNAC), even if the case falls in
low risk category. Since there is no role of elective neck
dissection in PTC, only therapeutic neck dissection in
the form of either central, unilateral, bilateral or contra
lateral was performed on the basis of positive neck node
found pre-operatively through neck examination and/or
imaging or intra-operatively through frozen section. All
pathology specimens were reviewed by two experienced
pathologists to confirm diagnosis, tumor characteristics
and the extent of disease. All tumors were staged
according to TNM staging system proposed by 2010
American Joint Committee on Cancer (AJCC).10 As this
was a retrospective study of routinely collected clinical
data, patient consent was not required.

What are the high risk pathological features?
Features including higher T-stage (T3/T4) and
N-stage (N1), bilaterality (tumor focus present in both
lobes of thyroid), multifocality (more than one tumor focus
present in either lobe of thyroid), distant metastasis,
extrathyroidal extention and vascular invasion in final
histopathology specimen are consider high risk as these
factors are poor prognostic correlates11 and indicator
for adjuvant radioactive iodine (RAI) therapy according
7

Statistical analysis

Association between obesity and the pathological
characteristics of PTC, as expressed in terms of odds ratio
(OR) with 95% confidence interval (CI). The pathological
factors of
PTC were treated as binary variables:
extrathyroidal extention (present or absent), multifocality
(present or absent), T stage (T1/T2 or T3/T4), bilaterality
(present or absent), N-stage (N0 or N1) and vascular
invasion (present or absent). All OR were adjusted for age
and gender.

Results
Baseline pathological characteristics
in patients with PTC
Pathological features of patients with PTC are
summarized in Table 1. Among 53 patients, 38 (71.7%)
were female and 15 (28.3%) were male. The mean age
was 44.6 ± 14.3 years (range, 12 to 80 years). Based
on WHO classification, there were 28(52.8%) normal and
25(47.1%) obese patients. Two (3.7%) subjects in normal
and three (5.6%) in obese category had known history
of diabetes mellitus, hypercholesterolemia and smoking.
Similarly, three (5.6%) cases in each group had thyroid
dysfunction which was preoperatively corrected. None
of our patients had history of alcohol intake. Forty-three
percent tumors had higher T-stage i.e. T3 and T4 while
more than 10% cases had multifocal and bilateral PTCs
along with extrathyroidal extention in final pathology
specimens. Vascular invasion was found in 10(18.9%)
cases while neck node metastasis was present in more
than 40%. Only 2 cases (3.7%) with BMI in obese group
had distant metastasis to lungs at the time of initial
presentation.
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weight and risk of developing thyroid and other types of
cancer.2-5 In a study done by Sung et al. 16, greater the
height, higher the chances of developing thyroid cancer in
both genders. Previous studies exploring the associations
between obesity and pathological features of PTC
reported inconsistent results. Study from South Korea9
showed a favorable relation between obesity and tumor
stage, even though the association was not statistically
significant. On the other hand, research from Ohio State
University Medical Center8 reported lower risk of tumor
invasiveness & nodal metastasis with excessive BMI. Our
study also showed no association between obesity & poor
pathological features namely extrathyroidal extension,
vascular invasion, tumor size and cervical metastasis.
Unlike Kim et al.11, which described strong relationship
of higher BMI with large tumor size, microscopic
extrathyroidal invasion and advanced tumor-nodemetastasis stage, our study showed positive link with
only multifocal and bilateral tumors. There have been
number of prior studies about the origin of multifocal and
bilateral PTC foci with evidence supporting two opinions,
i.e., de novo carcinogenesis or intrathyroidal metastasis.
But why multifocal and bilateral tumor foci had favorable
association with obesity, we unable to explain. Similarly,
the negative connection between elevated weight,
pathological features of tumor and clinical course is
unknown. One explanation for this when compared to
breast cancer in which obesity has strong relationship
with poor clinical behavior of tumor is that the amount
of adipose tissue in the thyroid is significantly lesser than
breast tissue. This cancer-adipocyte interaction may be
the cause of difference in behavior in these two types of
malignancy. Furthermore, certain cytokines such as leptin
released from fat cells are also involved on thyroid cancer
progression.17 Prior researches reported high blood
levels of leptin along-with expression of its receptor in
patients with PTC. Akinci et al.18 and Cheng et al. 19 also
described this leptin-tumor aggressiveness correlation
in their published papers. Conversely, adiponectin levels
were shown to be negatively associated with body fat and
BMI 17 and circulating adiponectin was inversely linked
with the risk of thyroid cancer.20 Additional researches
required to find out the potential mechanisms underlying
the interaction between obesity and high risk features in
papillary thyroid cancer.

Table 1: Baseline characteristics of patients with papillary
thyroid carcinoma (PTC)
Acronyms: n = number of cases; BMI = body mass index; T
stage = tumor stage; N stage = nodal stage

Associations between BMI and pathological
features of PTC
Patients who were obese had a significantly greater
risk of having a multifocal tumor (OR=5.55, p-value=0.02)
and bilaterality (OR=6.54, p-value=0.01) compared to
normal. Cases in obese group also had higher frequencies
of advanced T-stage and N-stage tumors along with
lesions having extrathyroidal extention and vascular
invasion, but it was not statistically significant (Table 2).

Discussion
In literature many studies on the correlations between
thyroid cancer, specifically papillary thyroid carcinoma
and obesity have been published.13-16 However there
were variations that exists in majority of studies due to
which there is no definite conclusion on the association
between obesity and thyroid malignancy. According to
Renehan et al. 4, higher incidence of thyroid malignancy
has been associated with increased BMI. Other works
also suggested positive link between excessive body

In the future, we are planning to follow these cases for
longer duration to detect whether this positive or negative
association of obesity with high risk pathological features
has impact on tumor recurrence or not.
The limitations of our study was its retrospective
nature, small sample size and lack of information
regarding physical activity. We only selected patients
8
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Table 2. Association of BMI and pathological features in patients with PTC
Acronyms: n = number of cases; BMI = body mass index; OR = odds ratio; CI = confidence interval; T stage = tumor stage; N stage
= nodal stage

who underwent total thyroidectomy and not included
those in which lobectomy was performed. Although BMI
determinations have been the most commonly used
assessment scale for obesity in the medical practice,
but measurements such as waist circumference, neck
circumference and skin-fold thickness may be better
tools for this type of study.

Conclusion
In the end, we conclude that obesity is not associated
with high risk pathological features such as extrathyroidal
extention, high T-stage, vascular invasion and N-stage in
PTC. Although it has been correlated with multifocal and
bilateral tumors in this retrospective study, the presence
of these factors alone is not adequate to support the
association conclusively. Further corroborative studies to
confirm these findings are essential.

9
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